Abstract
Restenosis of the dilated segment following percutaneous transluminal angioplasty is a commonly occurring problem. Several techniques such as pharmacologic agents, directional atherectomy, and endovascular stenting have been attempted with little success. This article gives an outline on the scope of the problem of restenosis, its pathophysiology, attempted treatments, and the promise of coronary vascular radiation therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
